Envoy Medical (COCH) FCF Margin (2022 - 2026)

Envoy Medical has disclosed FCF Margin across 5 years of filings, most recently posting 10698.04% for Q2 2026.

• In Q2 2026, FCF Margin fell 497881.0% year-over-year to 10698.04%; the TTM figure through Jun 2026 stood at 10485.51% (down 312335.0% YoY), while the FY2025 annual figure was 7626.56%, up 78633.0% from the prior year.
• FCF Margin came in at 10698.04% for Q2 2026 at Envoy Medical, up from 15541.03% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 1296.25% in Q3 2023 to a low of 15541.03% in Q1 2026.
• Average FCF Margin over 5 years is 8423.0%, with a median of 8663.42% recorded in 2022.
• Year-over-year, FCF Margin jumped 1051222 bps in 2023 and sank 771589 bps in 2024.
• Over 5 years, FCF Margin stood at 12100.0% in 2022, then climbed by 3 bps to 11753.68% in 2023, then climbed by 8 bps to 10850.0% in 2024, then rose by 29 bps to 7744.0% in 2025, then tumbled by 38 bps to 10698.04% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 10698.04% in Q2 2026, 15541.03% in Q1 2026, and 7744.0% in Q4 2025.